MIT's Catherine D'Ignazio is using data to address social issues and empower marginalized groups, focusing on projects like AI tools for documenting feminicide in Latin America.

MIT's Electrified Thermal Solutions has developed electrically conductive firebricks capable of reaching over 3,000 degrees Fahrenheit, aiming to decarbonize industrial heating.

MIT researchers designed a promising cancer vaccine aimed at enhancing the efficacy of immune checkpoint blockade therapies against heterogeneous tumors.

MIT researchers have developed an AI tool that can predict the impact of flooding using realistic satellite imagery, aiming to improve disaster preparedness.

MIT, Harvard, and Mass General Brigham lead a consortium that has initiated two renewable energy projects adding 408 MW to the grid to combat climate change.

MIT's AVT Consortium studies driver interactions with autonomous technologies, aiming to cultivate trust in AI to ensure the adoption and potential of automated vehicles.

MIT researchers developed a new algorithm improving AI training efficiency, promising better reliability for AI in various applications like traffic management.

MIT and Brigham and Women's Hospital engineers, with Novo Nordisk, developed a capsule for drug delivery inspired by squids, potentially replacing injections.

Emvolon, an MIT spinout, repurposes automotive engines to convert methane into green fuels directly at sources like landfills, promising to revolutionize sustainable energy and reduce emissions.

MIT physicists found that electrons can split into fractions, a behavior observed in pentalayer graphene that challenges conventional knowledge and suggests new electronic states.

Kunal Singh, an MIT PhD candidate, explores counterproliferation strategies in his research to prevent nuclear weapons spread, offering insights for policymakers.

Harvard researchers have developed a new gene editing technique called Helicase-Assisted Continuous Editing (HACE), allowing precise mutations in specific genes, enhancing targeted genetic research.

SiPhox Health, co-founded by MIT researchers, is developing a home-based blood testing device using silicon photonic chips to streamline chronic illness monitoring.